Spots Global Cancer Trial Database for KSH01-R02-101 Solid Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: KSH01-R02-101 Solid Tumors
Official Title: Investigator Initiated Clinical Trial on the Tolerance, Safety and Preliminary Efficacy of KSH01-TCRT Injection in Solid Tumor Subjects
Study ID: NCT05580796
Conditions
Interventions
Study Description
Brief Summary: 1. . safety and tolerance 2. . objective response rate
Detailed Description: 1. . To evaluate the safety and tolerance of autologous TCR-T cells in target positive solid tumor patients. 2. . Preliminary evaluation of objective response rate (ORR) of autologous TCR-T cells in target positive solid tumor patients (such as esophageal cancer, gastric cancer, head and neck cancer, bladder cancer, melanoma, sarcoma, etc.)
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Chinese People's Liberation Army (PLA) General Hospital, Beijing, Beijing, China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
